Le Lézard
Classified in: Health, Business
Subjects: PER, CXP, MAT

Shryne Group Continues Retail Expansion; Opens Third Store in California


LOS ANGELES, Oct. 21, 2019 /PRNewswire-PRWeb/ -- Shryne Group announced today that it will open its third STIIIZY store in California on Saturday, October 26. Located in Davis, just west of Sacramento, the new store comes on the heels of STIIIZY Downtown Los Angeles and STIIIZY Mission in San Francisco, which opened in the last three months. The company expects to have eight stores open in the Golden State by the end of the year.

The company also announced the hiring of Tak Sato as its chief development officer. Sato led retail expansion for leading cannabis retailer MedMen, acquiring over 40 licenses through transactions and competitive application processes.

"As we expand our retail footprint in California, the largest cannabis market in the world, it's imperative that we draw on top talent with proven track records," said Brian Mitchell, chief executive officer and co-founder of Shryne Group. "Tak's extensive knowledge of license acquisition will position Shryne Group for success as we continue to execute on our plan."

"Shryne Group has strong fundamentals and the right priorities," said Sato. "We will continue to keep our heads down and deliver results."

The company plans to open additional stores shortly in San Francisco's Union Square, Modesto, and Palm Desert with more to come. For more information on Shryne Group's vertically integrated footprint visit http://www.shrynegroup.com.

STIIIZY Davis is located at 965 Olive Drive, Suite G-1 and will be open from 10 am to 10 pm Monday through Sunday.

About STIIIZY
Founded in 2017, STIIIZY is one of the fastest-growing cannabis brands in the world. Best known for innovation and premium quality concentrates and products, the brand's "Influence, Inspire, Innovate" message has connected with avid fans in California, Nevada, Washington and Michigan. STIIIZY is part of the Shryne Group portfolio of cannabis assets. For more information, visit http://www.stiiizy.com.

About Shryne Group
Shryne Group Inc. is a Los Angeles-based cannabis holding company with a fully, vertically integrated asset and license portfolio covering the breadth of California, the largest legal cannabis market in the world. The enterprise is the result of the synergetic integration of profitable cannabis assets and veteran professionals who have come together for the opportunity to shape this industry. Our vision is informed by an intimate understanding of cannabis culture, its history and the collective expertise of decades of experience in diverse fields. Our STIIIZY product line is one of the best-selling cannabis brands in the market today. We are rooted in California, but currently have operations in Nevada, Washington and Michigan, and distribution networks to future markets in more than 60 countries.

 

SOURCE Shryne Group


These press releases may also interest you

at 16:05
The Peck Company Holdings, Inc. (the "Company" or "Peck"), a leading commercial solar engineering, procurement and construction (EPC) company, today announced the Company's financial results for the fourth quarter ("Q4 2019") and year ended December...

at 16:05
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today provided a corporate update and reported financial results for the fourth...

at 16:05
EACO Corporation today reported the results for its quarter ended February 29, 2020. Net sales, net income and earnings per share were as follows for the three months ended February 29, 2020 (dollars in thousands, except per share information):...

at 16:05
IZEA Worldwide, Inc. , operator of IZEAx, the premier online marketplace connecting brands and publishers with influential content creators, reported its financial and operational results for the fourth quarter and full year ended December 31, 2019....

at 16:05
Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product categories across the adult-use market Established Cronos Fermentation, a critical step in...

at 16:03
Titan Pharmaceuticals, Inc. ("Titan" or the "Company") today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided an update on its business....



News published on 21 october 2019 at 09:00 and distributed by: